Pelthos Therapeutics PTHS
NYSE PTHS
$26.29 -0.37 (-1.39%)
As of: Aug 21, 2026 · 11:38 AM EDT

Pelthos Therapeutics (PTHS) Debt Ratio (2022 - 2026)

Pelthos Therapeutics (PTHS) posted quarterly Debt Ratio of 0.16 for Q2 2025, up 216.41% year-over-year from 0.05 in Q2 2024, and up 10.73% quarter-over-quarter from 0.14 in Q1 2025.

Pelthos Therapeutics (PTHS) Debt Ratio (2022 - 2026) Analysis & Trends

Pelthos Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.16 for Q2 2025.

  • In Q2 2025, Debt Ratio rose 216.41% year-over-year to 0.16; the TTM figure through Jun 2025 stood at 0.16 (up 216.41% YoY), while the FY2024 annual figure was 0.19, down 97.52% from the prior year.
  • Debt Ratio for Q2 2025 stood at 0.16, up from 0.14 in the prior quarter.
  • The five-year high for Debt Ratio was 7.78 in Q4 2023, with the low at 0.05 in Q2 2024.
  • The 4-year median for Debt Ratio is 0.16 (2025), against an average of 1.47.
  • The sharpest annual moves came in 2023 and 2024: Debt Ratio soared 308.94% in 2023, then tumbled 97.52% in 2024.
  • Pelthos Therapeutics' Debt Ratio stood at 1.9 in 2022, then soared by 308.94% to 7.78 in 2023, then sank by 97.52% to 0.19 in 2024, then slipped by 16.9% to 0.16 in 2025.
  • Business Quant data shows PTHS's Debt Ratio at 0.16 in Q2 2025, 0.14 in Q1 2025, and 0.19 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.90 Bn 132.05 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 86.70 Bn 78.71 Bn 3.93 Bn 0.05
3 Argenx Se 65.73 Bn 60.55 Bn 1.37 Bn -
4 Moderna 58.33 Bn 53.19 Bn 52.00 Mn 0.05
5 BeOne Medicines 42.16 Bn 37.07 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.72 Bn 28.42 Bn 992.69 Mn -
7 BioNTech SE 28.27 Bn 9.88 Bn 668.28 Mn 0.03
8 Insmed 27.61 Bn 26.45 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.25 Bn 26.41 Bn - 0.47
10 Pelthos Therapeutics 93.05 Mn 68.49 Mn 21.23 Mn 0.19

Historic Data

Download Data
DateValue
Jun 30, 2026 0.19
Jun 30, 2025 0.16
Mar 31, 2025 0.14
Dec 31, 2024 0.19
Sep 30, 2024 0.06
Jun 30, 2024 0.05
Dec 31, 2023 7.78
Dec 31, 2022 1.90